아스트루멧

비상장계속사업자

ASTRUMET INC.

조용범

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

아스트루멧

Business Reg. No. 1538100808 · CEO 조용범

I.Investment Overview

Target아스트루멧 (1538100808)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명아스트루멧
영문명ASTRUMET INC.
대표자조용범
사업자등록번호1538100808
법인등록번호2850110354336
설립일2017.05.12
종업원수5명

V.Workforce

5

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW95920211,251.420222,282.420231,552.620242,308.62025
영업이익100M KRW28.1202116.8202211.9202312.720249.92025
순이익100M KRW21.9202115.320229.720239.220249.22025
Item20252024202320222021
자산총계156억원139.9억원102.7억원83.9억원50.9억원
부채총계85억원77.1억원47.6억원37억원18.2억원
자본총계71억원62.8억원55.1억원46.9억원32.6억원
매출액2,308.6억원1,552.6억원2,282.4억원1,251.4억원959억원
영업이익9.9억원12.7억원11.9억원16.8억원28.1억원
순이익9.2억원9.2억원9.7억원15.3억원21.9억원

VII.Financial Ratios

FY2025 basis

0.43%

영업이익률

0.4%

순이익률

5.89%

ROA

12.94%

ROE

119.8%

부채비율

45.5%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

아스트루멧 투심보고서 | Alpha Lenz